Literature DB >> 26619928

Donor gluconate rescues livers from uncontrolled donation after cardiac death.

Ashley Limkemann1, Susanne L Lindell1, Heather Reichstetter1, Valerie Plant1, Dan Parrish1, Clementina Ramos1, Chris Kowalski1, Cristiano Quintini2, Martin J Mangino3.   

Abstract

BACKGROUND: Ischemia from organ preservation or donation causes cells and tissues to swell owing to loss of energy-dependent mechanisms of control of cell volume. These volume changes cause substantial preservation injury, because preventing these changes by adding cell impermeants to preservation solutions decreases preservation injury. The objective of this study was to assess if this effect could be realized early in uncontrolled donation after cardiac death (DCD) livers by systemically loading donors with gluconate immediately after death to prevent accelerated swelling injury during the warm ischemia period before liver retrieval.
METHODS: Uncontrolled DCD rat livers were cold-stored in University of Wisconsin solution for 24 hours and reperfused on an isolated perfused liver (IPL) device for 2 hours or transplanted into a rat as an allograft for 7 days. Donors were pretreated with a solution of the impermeant gluconate or a saline control immediately after cardiac death. Livers were retrieved after 30 minutes.
RESULTS: In vivo, gluconate infusion in donors immediately before or after cardiac death prevented DCD-induced increases in total tissue water, decreased vascular resistance, increased oxygen consumption and synthesis of adenosine triphosphate, increased bile production, decreased lactate dehydrogenase release, and decreased histology injury scores after reperfusion on the IPL relative to saline-treated DCD controls. In the transplant model, donor gluconate pretreatment significantly decreased both alanine aminotransferase the first day after transplantation and total bilirubin the seventh day after transplantation.
CONCLUSION: Cell and tissue swelling plays a key role in preservation injury of uncontrolled DCD livers, which can be mitigated by early administration of gluconate solutions to the donor immediately after death.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26619928      PMCID: PMC4744557          DOI: 10.1016/j.surg.2015.10.022

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  31 in total

1.  Donation after cardiac death liver transplantation: predictors of outcome.

Authors:  A K Mathur; J Heimbach; D E Steffick; C J Sonnenday; N P Goodrich; R M Merion
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

2.  Donation after cardiac death: the University of Wisconsin experience with liver transplantation.

Authors:  David P Foley; Luis A Fernandez; Glen Leverson; L Thomas Chin; Nancy Krieger; Jeffery T Cooper; Brian D Shames; Yolanda T Becker; Jon S Odorico; Stuart J Knechtle; Hans W Sollinger; Munci Kalayoglu; Anthony M D'Alessandro
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

3.  Ezrin functionality and hypothermic preservation injury in LLC-PK1 cells.

Authors:  Tao Tian; Susanne L Lindell; Melody Lam; Martin J Mangino
Journal:  Cryobiology       Date:  2012-04-23       Impact factor: 2.487

4.  Report of a National Conference on Donation after cardiac death.

Authors:  J L Bernat; A M D'Alessandro; F K Port; T P Bleck; S O Heard; J Medina; S H Rosenbaum; M A Devita; R S Gaston; R M Merion; M L Barr; W H Marks; H Nathan; K O'connor; D L Rudow; A B Leichtman; P Schwab; N L Ascher; R A Metzger; V Mc Bride; W Graham; D Wagner; J Warren; F L Delmonico
Journal:  Am J Transplant       Date:  2006-02       Impact factor: 8.086

5.  Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity.

Authors:  C Steenbergen; M L Hill; R B Jennings
Journal:  Circ Res       Date:  1985-12       Impact factor: 17.367

6.  [Importance of graft arterialization in rat liver transplantation].

Authors:  T S Lie; H H Hansen; K J Niehaus
Journal:  Langenbecks Arch Chir       Date:  1983

7.  Preservation methods for kidney and liver.

Authors:  Charles Y Lee; Martin J Mangino
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

8.  Cytoskeletal involvement in hypothermic renal preservation injury.

Authors:  Martin J Mangino; Tao Tian; Mary Ametani; Susanne Lindell; James H Southard
Journal:  Transplantation       Date:  2008-02-15       Impact factor: 4.939

9.  The hepatoprotective effect of sodium nitrite on cold ischemia-reperfusion injury.

Authors:  Wei Li; Zihui Meng; Yuliang Liu; Rakesh P Patel; John D Lang
Journal:  J Transplant       Date:  2012-02-28

10.  Mouse IPK: A Powerful Tool to Partially Characterize Renal Reperfusion and Preservation Injury.

Authors:  Susanne L Lindell; Natascha Williams; Ilia Brusilovsky; Martin J Mangino
Journal:  Open Transplant J       Date:  2011-01-01
View more
  2 in total

Review 1.  The promise of organ and tissue preservation to transform medicine.

Authors:  Sebastian Giwa; Jedediah K Lewis; Luis Alvarez; Robert Langer; Alvin E Roth; George M Church; James F Markmann; David H Sachs; Anil Chandraker; Jason A Wertheim; Martine Rothblatt; Edward S Boyden; Elling Eidbo; W P Andrew Lee; Bohdan Pomahac; Gerald Brandacher; David M Weinstock; Gloria Elliott; David Nelson; Jason P Acker; Korkut Uygun; Boris Schmalz; Brad P Weegman; Alessandro Tocchio; Greg M Fahy; Kenneth B Storey; Boris Rubinsky; John Bischof; Janet A W Elliott; Teresa K Woodruff; G John Morris; Utkan Demirci; Kelvin G M Brockbank; Erik J Woods; Robert N Ben; John G Baust; Dayong Gao; Barry Fuller; Yoed Rabin; David C Kravitz; Michael J Taylor; Mehmet Toner
Journal:  Nat Biotechnol       Date:  2017-06-07       Impact factor: 54.908

Review 2.  Social, economic, and policy implications of organ preservation advances.

Authors:  Alyssa Ward; David K Klassen; Kate M Franz; Sebastian Giwa; Jedediah K Lewis
Journal:  Curr Opin Organ Transplant       Date:  2018-06       Impact factor: 2.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.